Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis.

Golan D, Staun-Ram E, Glass-Marmor L, Lavi I, Rozenberg O, Dishon S, Barak M, Ish-Shalom S, Miller A.

Brain Behav Immun. 2013 Aug;32:180-5. doi: 10.1016/j.bbi.2013.04.010. Epub 2013 May 7.

PMID:
23665342
2.

Suboptimal effect of different vitamin D3 supplementations and doses adapted to baseline serum 25(OH)D on achieved 25(OH)D levels in patients with a recent fracture: a prospective observational study.

Shab-Bidar S, Bours SP, Geusens PP, van der Velde RY, Janssen MJ, van den Bergh JP.

Eur J Endocrinol. 2013 Oct 1;169(5):597-604. doi: 10.1530/EJE-13-0068. Print 2013 Nov.

3.

Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.

Smolders J, Hupperts R, Barkhof F, Grimaldi LM, Holmoy T, Killestein J, Rieckmann P, Schluep M, Vieth R, Hostalek U, Ghazi-Visser L, Beelke M; SOLAR study group.

J Neurol Sci. 2011 Dec 15;311(1-2):44-9. doi: 10.1016/j.jns.2011.04.013. Epub 2011 May 28.

PMID:
21620416
4.

Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.

Hiremath GS, Cettomai D, Baynes M, Ratchford JN, Newsome S, Harrison D, Kerr D, Greenberg BM, Calabresi PA.

Mult Scler. 2009 Jun;15(6):735-40. doi: 10.1177/1352458509102844. Epub 2009 Apr 21.

PMID:
19383644
5.

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.

Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, Gagne D, D'Souza C, Ursell M, O'Connor P.

Neurology. 2010 Jun 8;74(23):1852-9. doi: 10.1212/WNL.0b013e3181e1cec2. Epub 2010 Apr 28. Erratum in: Neurology. 2010 Aug 3;75(5):480. Neurology. 2010 Sep 14;75(11):1029. Dosage error in article text.

6.

Sunlight exposure or vitamin D supplementation for vitamin D-deficient non-western immigrants: a randomized clinical trial.

Wicherts IS, Boeke AJ, van der Meer IM, van Schoor NM, Knol DL, Lips P.

Osteoporos Int. 2011 Mar;22(3):873-82. doi: 10.1007/s00198-010-1343-x. Epub 2010 Aug 4.

7.

Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis.

Melamud L, Golan D, Luboshitzky R, Lavi I, Miller A.

J Neurol Sci. 2012 Mar 15;314(1-2):37-40. doi: 10.1016/j.jns.2011.11.003. Epub 2011 Dec 1.

PMID:
22137446
8.

Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta.

Åivo J, Hänninen A, Ilonen J, Soilu-Hänninen M.

J Neuroimmunol. 2015 Mar 15;280:12-5. doi: 10.1016/j.jneuroim.2015.01.005. Epub 2015 Jan 21.

PMID:
25773149
9.

Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis.

Jelinek GA, Marck CH, Weiland TJ, Pereira N, van der Meer DM, Hadgkiss EJ.

BMC Neurol. 2015 Aug 5;15:132. doi: 10.1186/s12883-015-0394-1.

10.

Skeletal and hormonal responses to vitamin D supplementation during sunlight deprivation in Antarctic expeditioners.

Iuliano-Burns S, Ayton J, Hillam S, Jones G, King K, Macleod S, Seeman E.

Osteoporos Int. 2012 Oct;23(10):2461-7. doi: 10.1007/s00198-011-1858-9. Epub 2012 Jan 4.

PMID:
22215183
11.

Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties.

Golan D, Halhal B, Glass-Marmor L, Staun-Ram E, Rozenberg O, Lavi I, Dishon S, Barak M, Ish-Shalom S, Miller A.

BMC Neurol. 2013 Jun 14;13:60. doi: 10.1186/1471-2377-13-60.

12.

Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study.

Amrein K, Sourij H, Wagner G, Holl A, Pieber TR, Smolle KH, Stojakovic T, Schnedl C, Dobnig H.

Crit Care. 2011;15(2):R104. doi: 10.1186/cc10120. Epub 2011 Mar 28.

13.

The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, BMI, and baseline levels.

Didriksen A, Grimnes G, Hutchinson MS, Kjærgaard M, Svartberg J, Joakimsen RM, Jorde R.

Eur J Endocrinol. 2013 Oct 1;169(5):559-67. doi: 10.1530/EJE-13-0233. Print 2013 Nov.

14.

Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.

Smolders J, Peelen E, Thewissen M, Menheere P, Damoiseaux J, Hupperts R.

Mult Scler. 2014 Apr;20(4):433-7. doi: 10.1177/1352458513500552. Epub 2013 Aug 19.

PMID:
23959712
15.

The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis.

James E, Dobson R, Kuhle J, Baker D, Giovannoni G, Ramagopalan SV.

Mult Scler. 2013 Oct;19(12):1571-9. doi: 10.1177/1352458513489756. Epub 2013 May 22. Review.

PMID:
23698130
16.

Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis.

Zivadinov R, Treu CN, Weinstock-Guttman B, Turner C, Bergsland N, O'Connor K, Dwyer MG, Carl E, Ramasamy DP, Qu J, Ramanathan M.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1075-81. doi: 10.1136/jnnp-2012-304661. Epub 2013 Feb 5.

PMID:
23385850
17.

Long-term vitamin D3 supplementation is more effective than vitamin D2 in maintaining serum 25-hydroxyvitamin D status over the winter months.

Logan VF, Gray AR, Peddie MC, Harper MJ, Houghton LA.

Br J Nutr. 2013 Mar 28;109(6):1082-8. doi: 10.1017/S0007114512002851. Epub 2012 Jul 11.

PMID:
23168298
18.

Vitamin D status and impact of vitamin D3 and/or calcium supplementation in a randomized pilot study in the Southeastern United States.

McCullough ML, Bostick RM, Daniel CR, Flanders WD, Shaukat A, Davison J, Rangaswamy U, Hollis BW.

J Am Coll Nutr. 2009 Dec;28(6):678-86.

19.

What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?

Steffensen LH, Brustad M, Kampman MT.

J Neurol. 2013 Jan;260(1):182-8. doi: 10.1007/s00415-012-6611-6. Epub 2012 Aug 1.

PMID:
22850935
20.

No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year.

Jorde R, Sneve M, Torjesen PA, Figenschau Y, Hansen JB, Grimnes G.

Nutr J. 2010 Jan 7;9:1. doi: 10.1186/1475-2891-9-1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk